Another thought I had while reading the US CMS Medicare report for EPI ProColon (link is first post in this thread) was that the CMS seem to like to see substantial proof of test statistics demonstrated in a real world setting.
The US system, in which a CLIA labs endorses medical devices for sale without the need for TGA approval, allows for real world testing, thus establishing additional data in the process which can be used for both TGA and CMS approvals in the future.
The Epi ProColon report, dated Jan 2021, states that TGA approval is required prior to any CMS Medicare reimbursement approval, but the former does not guarantee the latter.
- Forums
- ASX - By Stock
- Holiday Research - US competitive landscape and pan-cancer detection
Another thought I had while reading the US CMS Medicare report...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
-0.003(4.29%) |
Mkt cap ! $16.65M |
Open | High | Low | Value | Volume |
6.5¢ | 6.7¢ | 6.5¢ | $4.616K | 70.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38161 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 34326 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38161 | 0.066 |
1 | 213342 | 0.065 |
2 | 110864 | 0.064 |
1 | 131025 | 0.063 |
2 | 15000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 34326 | 1 |
0.068 | 1128 | 1 |
0.070 | 86753 | 4 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |